Cocrystal Pharma Files 2024 10-K
Ticker: COCP · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Cocrystal Pharma (COCP) filed its 2024 10-K. Check financials.
AI Summary
Cocrystal Pharma, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as BIOZONE PHARMACEUTICALS, INC., is based in Bothell, WA. Key financial data points for the fiscal year 2024 and prior periods are included in the filing.
Why It Matters
This filing provides a comprehensive overview of Cocrystal Pharma's financial health and operational status for the past fiscal year, crucial for investors and stakeholders.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cocrystal Pharma faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-31 — Filing Date (Date the 10-K was submitted)
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Filer of the 10-K
- BIOZONE PHARMACEUTICALS, INC. (company) — Former name of Cocrystal Pharma
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- Bothell, WA (location) — Company address
FAQ
What is Cocrystal Pharma's primary business?
Cocrystal Pharma, Inc. is primarily involved in the Pharmaceutical Preparations industry, SIC code 2834.
When was Cocrystal Pharma previously known by another name?
Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC., with a name change effective March 4, 2011.
Where is Cocrystal Pharma located?
The company's business and mailing address is 19805 N. CREEK PARKWAY, BOTHELL, WA 98011.
What is the SEC file number for Cocrystal Pharma?
The SEC file number for Cocrystal Pharma is 001-38418.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Cocrystal Pharma, Inc. (COCP).